NextCure, Inc.
NXTC
$12.20
$0.241.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.25% | -17.60% | -16.50% | -19.12% | -20.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.72% | -0.37% | 0.31% | -19.99% | -15.42% |
| Operating Income | -0.72% | 0.37% | -0.31% | 19.99% | 15.42% |
| Income Before Tax | -0.34% | 0.87% | 0.57% | 22.30% | 11.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.34% | 0.87% | 0.57% | 22.30% | 11.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.34% | 0.87% | 0.57% | 22.30% | 11.27% |
| EBIT | -0.72% | 0.37% | -0.31% | 19.99% | 15.42% |
| EBITDA | -2.01% | -0.51% | -1.32% | 19.86% | 15.03% |
| EPS Basic | 9.64% | 3.78% | 1.66% | 22.63% | 11.67% |
| Normalized Basic EPS | 5.30% | -0.59% | -2.59% | 19.42% | 15.71% |
| EPS Diluted | 9.64% | 3.78% | 1.66% | 22.63% | 11.67% |
| Normalized Diluted EPS | 5.30% | -0.59% | -2.59% | 19.42% | 15.71% |
| Average Basic Shares Outstanding | 21.93% | 4.36% | 0.78% | 0.44% | 0.46% |
| Average Diluted Shares Outstanding | 21.93% | 4.36% | 0.78% | 0.44% | 0.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |